FAIR ISAAC CORP Earnings Per Share Disclosure
| Year Ended September 30, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| (In thousands, except per share data) | |||||||||||||||||
| Numerator for diluted and basic earnings per share: | |||||||||||||||||
| Net income | $ | 651,946 | $ | 512,811 | $ | 429,375 | |||||||||||
| Denominator — share: | |||||||||||||||||
| Basic weighted-average shares | 24,239 | 24,676 | 24,986 | ||||||||||||||
| Effect of dilutive securities | 322 | 403 | 381 | ||||||||||||||
| Diluted weighted-average shares | 24,561 | 25,079 | 25,367 | ||||||||||||||
| Earnings per share: | |||||||||||||||||
| Basic | $ | 26.90 | $ | 20.78 | $ | 17.18 | |||||||||||
| Diluted | $ | 26.54 | $ | 20.45 | $ | 16.93 | |||||||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Nov 7, 2025 | Showing above |
| 2024 | Nov 6, 2024 | |
| 2023 | Nov 8, 2023 | |
| 2022 | Nov 9, 2022 | |
| 2021 | Nov 10, 2021 | |
| 2020 | Nov 12, 2020 | |
| 2019 | Nov 8, 2019 | |
| 2018 | Nov 9, 2018 | |
| 2017 | Nov 9, 2017 | |
| 2016 | Nov 10, 2016 | |
| 2015 | Nov 10, 2015 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.